PharmiWeb.com - Global Pharma News & Resources

Press Releases

Date Title Company
14-Feb-2024 Global Healthcare Business Intelligence Market is expected to climb to US$ 7.4 Billion by 2032, as per FMI MARKITWIRED
14-Feb-2024 Global Healthcare API Market is expected to witness remarkable expansion, potentially reaching US$ 316.2 Million by 2033, driven mainly by the surge in telemedicine demand | FMI MARKITWIRED
14-Feb-2024 Global Microplate Instrumentation and Systems Market, estimating a 4.9% CAGR over the period spanning 2023 to 2033 MARKITWIRED
14-Feb-2024 Global Viral Vector Development Market is on track to attain a noteworthy value of US$ 4.1 billion by 2033 at a CAGR of 18.7% | FMI MARKITWIRED
14-Feb-2024 Global Veterinary Disinfectants for Pets and Farms Market is on track to exceed $7.3 Billion in valuation by 2033 MARKITWIRED
14-Feb-2024 Treadwell Announces the Formation and Members of Scientific Advisory Board Businesswire
14-Feb-2024 MEI Pharma Reports Second Quarter Fiscal Year 2024 Results and Operational Highlights Businesswire
14-Feb-2024 Kirby McInerney LLP Announces the Filing of a Securities Class Action on Behalf of Amylyx Pharmaceuticals, Inc. (AMLX) Investors Businesswire
14-Feb-2024 Vistagen Reports Fiscal 2024 Third Quarter Financial Results and Provides Corporate Update Businesswire
14-Feb-2024 Electromed, Inc. Announces Record Financial Performance in Fiscal 2024 Second Quarter Businesswire
14-Feb-2024 Immunome Announces Proposed Public Offering of Common Stock Businesswire
14-Feb-2024 Ligand to Report Fourth Quarter and Full Year 2023 Financial Results on February 27, 2024 Businesswire
13-Feb-2024 Temple Health Joins U.S. Study of Artificial Intelligence Diagnostic System for DVT Detection AccessWire
13-Feb-2024 Chowis Collaborates With L’Oréal Professionnel Paris in India to Revolutionize Hair Care Service AccessWire
13-Feb-2024 Nature Made® Introduces Advanced Multivitamin Gummies with a Unique Combination of 20 Essential Nutrients to Help Consumers Get the Daily Nutritional Support They Need Businesswire
13-Feb-2024 Areteia Therapeutics annonce un financement supplémentaire de série A de 75 millions USD pour le dexpramipexole oral dans la lutte contre l’asthme éosinophile Businesswire
13-Feb-2024 Areteia Therapeutics kündigt weitere 75 Millionen US-Dollar in Serie A-Finanzierung für orales Dexpramipexol bei eosinophilem Asthma an Businesswire
13-Feb-2024 Number of Shares and Voting Rights of ADOCIA as of January 31st, 2024 Businesswire
13-Feb-2024 MyMD Pharmaceuticals Announces Reverse Stock Split to Maintain Nasdaq Listing Businesswire
13-Feb-2024 CLOUD DX Signs Partnership Agreement with Sanrai International AccessWire